Department of Psychology, Umeå University, Umeå, Sweden.
Psychol Health Med. 2023 Apr;28(4):884-894. doi: 10.1080/13548506.2021.1985149. Epub 2021 Sep 29.
Despite sleep disturbance and somatic symptoms being common health complaints, the relationship between these disturbances and single somatic symptoms is not well documented. The objectives of this study were to (i) identify somatic symptoms that are particularly associated with sleep disturbance, here referred to as somatic symptoms related to sleep disturbance (SS-SD), (ii) determine increased risk of sleep disturbance for each SS-SD and for a certain number of SS-SD, with and without controlling for anxiety and depression, and (iii) determine sensitivity and specificity for identifying sleep disturbance based on number of SS-SD in a general Swedish sample. Population-based, cross-sectional data based on validated questionnaire instruments were used from participants who constituted a sleep disturbance (n = 864) or a reference (n = 2340) group. Among 15 common somatic symptoms, stomach pain, back pain nausea/gas/indigestion, dizziness, and constipation/loose bowels/diarrhea were identified as SS-SD, with odds ratios of increased risk of sleep disturbance that ranged from 1.93 to 2.44 (1.36-1.79 and 1.54-1.91 when controlled for anxiety and depression, respectively). The risk of sleep disturbance increased by 1.44 times for each SS-SD (1.25 and 1.30 when controlled for anxiety and depression, respectively). A cutoff of two/three or more SS-SD had a sensitivity of 72.5/54.2% and a specificity of 50.0/69.7% for identifying sleep disturbances. When patients present with these somatic symptoms with or without a pathophysiological explanation, primary care clinicians may consider screening for sleep disturbance.
尽管睡眠障碍和躯体症状是常见的健康问题,但这些问题之间的关系以及单一躯体症状与睡眠障碍的关系尚未得到充分记录。本研究的目的是:(i)确定与睡眠障碍特别相关的躯体症状,即与睡眠障碍相关的躯体症状(SS-SD);(ii)确定每个 SS-SD 以及一定数量的 SS-SD 是否会增加睡眠障碍的风险,同时是否控制焦虑和抑郁;(iii)确定在一般瑞典样本中,基于 SS-SD 的数量来识别睡眠障碍的敏感性和特异性。本研究使用了基于验证问卷的基于人群的横断面数据,参与者分为睡眠障碍组(n=864)和参考组(n=2340)。在 15 种常见躯体症状中,胃痛、背痛、恶心/气体/消化不良、头晕和便秘/腹泻/腹泻被确定为 SS-SD,与睡眠障碍相关的风险比为 1.93-2.44(分别为 1.36-1.79 和 1.54-1.91,当控制焦虑和抑郁时)。每个 SS-SD 会使睡眠障碍的风险增加 1.44 倍(分别为 1.25 和 1.30,当控制焦虑和抑郁时)。当存在两个/三个或更多 SS-SD 时,识别睡眠障碍的敏感性为 72.5%/54.2%,特异性为 50.0%/69.7%。当患者出现这些躯体症状,无论是否存在病理生理学解释,初级保健临床医生都可能考虑筛查睡眠障碍。